查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1565149

全球神經義肢市場

Neuroprosthetics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球神經修復術市場預計將達到 252 億美元

預計 2023 年全球神經修復市場將達到 114 億美元，預計在 2023 年至 2030 年分析期間將以 12.0% 的複合年成長率成長，並在 2030 年達到 252 億美元。運動神經元疾病應用是本報告分析的細分市場之一，預計複合年成長率為 13.5%，到分析期結束時將達到 158 億美元。分析期內認知障礙應用領域的複合年成長率預計為10.9%。

美國市場預估30億美元，中國預期複合年成長率10.9%

到 2023 年，美國神經修復市場預計將達到 30 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達38億美元，2023-2030年分析期間複合年成長率為10.9%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間複合年成長率分別為 11.1% 和 9.9%。在歐洲，德國的複合年成長率預計為 8.2%。

全球神經修復市場 - 主要趨勢和促進因素總結

什麼是神經修復術以及為什麼它們具有變革性？

神經假體是先進的醫療設備，可與神經系統連接，恢復或增強因損傷、疾病或先天性疾病而喪失的神經功能。透過向神經系統的特定區域發送電訊號，這些設備可以取代或輔助運動控制、感官知覺甚至認知功能等功能。神經修復術的常見例子包括用於聽力恢復的人工電子耳、用於治療帕金森氏症的深部腦刺激（DBS）設備以及允許癱瘓患者控制機器人肢體的腦機介面等。

神經修復術的變革性在於它們能夠幫助嚴重殘疾的人恢復獨立並提高生活品質。這些設備為治療多種神經系統疾病（包括癲癇、中風和脊髓損傷）開闢了新的可能性。隨著神經假體技術的不斷進步，開發能夠與大腦即時互動的更複雜系統的可能性正在成為現實，為世界各地數百萬名患者帶來了新的希望。

神經修復市場如何發展？

由於材料科學、神經科學和生物技術的進步，神經修復市場正在迅速發展。該市場最重要的趨勢之一是開發不需要外部電線或笨重硬體的無線神經假體系統。此類無線設備為患者提供更大的移動性和舒適度，同時降低與有線系統相關的感染風險。此外，神經假體組件的小型化可以與身體無縫整合，從而提高設備的功能和美觀性。

另一個重要趨勢是機器學習和人工智慧在神經修復術中的使用越來越多。透過結合人工智慧演算法，這些設備可以學習患者的神經模式並適應他們的特定需求，從而提供更個人化和有效的治療。這對於腦機介面（BCI）來說尤其重要，它依靠腦波訊號的即時分析來控制機器人肢體等外部設備。隨著人工智慧技術的進步，神經假體預計將變得更加直覺和靈敏，從而進一步增加其對患者生活的影響。

哪些疾病會促進神經修復術的普及？

幾種神經系統疾病正在推動神經修復術的採用，其中最著名的是聽力損失、帕金森氏症和癱瘓。人工電子耳是使用最廣泛的神經義肢假體，正在幫助數百萬嚴重聽力損失的人恢復聽力。這些設備繞過耳朵受損部分，直接刺激聽覺神經，為聲音訊號到達大腦提供清晰的途徑。

在帕金森氏症的治療中，深部腦部刺激 (DBS) 設備透過提供控制震顫和僵硬等運動症狀的方法，徹底改變了患者護理。 DBS 設備向大腦的特定區域發送電脈衝，以控制異常的神經活動。同樣，用於脊髓損傷和癱瘓的義肢假體也變得越來越普遍。這些設備通常與腦機介面結合，使癱瘓患者能夠利用他們的思想來操縱機器人肢體和外骨骼，從而使以前無法達到的活動水平得到恢復。

神經假體市場的主要成長動力是什麼？

神經修復市場的成長受到多種因素的推動。主要因素之一是聽力損失、癲癇、帕金森氏症和脊髓損傷等神經系統疾病的盛行率不斷增加。隨著世界人口老化，這些疾病的盛行率預計將增加，從而增加對神經修復解決方案的需求。另一個主要驅動力是材料、人工智慧和生物工程的快速進步，這些進步使神經修復術更加有效、更舒適，並且可供更多患者使用。

對個人化醫療的日益關注也推動了市場的發展，矯正器具正在根據個別患者的特定需求進行客製化。此外，神經學研究和開發投資的增加以及醫療設備有利的法規環境正在為創新和市場擴張創造機會。增加公共和私人對神經假體研究（尤其是腦機介面）的資助，正在進一步加速該市場的成長。

受訪企業範例（44家知名企業）

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • NDI Medical
  • NeuroPace, Inc.
  • Nevro Corp.
  • Retina Implant AG
  • Second Sight Medical Products, Inc.
  • Sonova Holding AG

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP13580

Global Neuroprosthetics Market to Reach US$25.2 Billion by 2030

The global market for Neuroprosthetics estimated at US$11.4 Billion in the year 2023, is expected to reach US$25.2 Billion by 2030, growing at a CAGR of 12.0% over the analysis period 2023-2030. Motor Neuron Disorders Application, one of the segments analyzed in the report, is expected to record a 13.5% CAGR and reach US$15.8 Billion by the end of the analysis period. Growth in the Cognitive Disorders Application segment is estimated at 10.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.0 Billion While China is Forecast to Grow at 10.9% CAGR

The Neuroprosthetics market in the U.S. is estimated at US$3.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.8 Billion by the year 2030 trailing a CAGR of 10.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.1% and 9.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.

Global Neuroprosthetics Market - Key Trends & Drivers Summarized

What Are Neuroprosthetics and Why Are They Transformative?

Neuroprosthetics are advanced medical devices that interface with the nervous system to restore or enhance neurological functions that have been lost due to injury, disease, or congenital conditions. These devices can replace or assist functions such as motor control, sensory perception, and even cognitive functions by sending electrical signals to specific areas of the nervous system. Common examples of neuroprosthetics include cochlear implants for hearing restoration, deep brain stimulation (DBS) devices for Parkinson’s disease, and brain-machine interfaces that enable paralyzed individuals to control robotic limbs.

The transformative nature of neuroprosthetics lies in their ability to restore independence and improve the quality of life for individuals with severe disabilities. These devices have opened new possibilities in treating a wide range of neurological disorders, including epilepsy, stroke, and spinal cord injuries. As advancements in neuroprosthetic technology continue, the potential for developing more sophisticated systems that can interact with the brain in real-time is becoming a reality, offering new hope to millions of patients worldwide.

How Is the Neuroprosthetics Market Evolving?

The neuroprosthetics market is evolving rapidly, driven by advances in materials science, neuroscience, and bioengineering. One of the most significant trends in this market is the development of wireless neuroprosthetic systems that eliminate the need for external wires or bulky hardware. These wireless devices provide greater mobility and comfort for patients, while also reducing the risk of infection associated with wired systems. Additionally, the miniaturization of neuroprosthetic components has enabled more seamless integration with the body, improving both the functionality and aesthetic appeal of the devices.

Another key trend is the increasing use of machine learning and AI in neuroprosthetics. By incorporating AI algorithms, these devices can learn from a patient's neural patterns and adapt to their specific needs, providing more personalized and effective treatment. This is particularly important for brain-computer interfaces (BCIs), which rely on real-time analysis of brain signals to control external devices such as robotic limbs. As AI technology continues to advance, neuroprosthetics are expected to become more intuitive and responsive, further enhancing their impact on patients’ lives.

Which Conditions Are Driving Neuroprosthetic Adoption?

Several neurological conditions are driving the adoption of neuroprosthetics, with the most prominent being hearing loss, Parkinson’s disease, and paralysis. Cochlear implants, the most widely used neuroprosthetic devices, have helped millions of individuals with severe hearing impairments regain the ability to hear. These devices work by bypassing damaged parts of the ear and directly stimulating the auditory nerve, providing a clear path for sound signals to reach the brain.

In the treatment of Parkinson’s disease, deep brain stimulation (DBS) devices have revolutionized patient care by providing a means of controlling motor symptoms such as tremors and rigidity. DBS devices send electrical impulses to specific areas of the brain to regulate abnormal neural activity. Similarly, neuroprosthetic devices for spinal cord injuries and paralysis are gaining traction. These devices, often coupled with brain-computer interfaces, enable paralyzed patients to control robotic limbs or exoskeletons using their thoughts, restoring a level of mobility that was previously unattainable.

What Are the Key Growth Drivers in the Neuroprosthetics Market?

The growth in the neuroprosthetics market is driven by several factors. One of the primary drivers is the increasing prevalence of neurological disorders, including hearing loss, epilepsy, Parkinson’s disease, and spinal cord injuries. As the global population ages, the incidence of these conditions is expected to rise, driving demand for neuroprosthetic solutions. Another major driver is the rapid pace of technological advancements in materials, AI, and bioengineering, which are making neuroprosthetics more effective, comfortable, and accessible to a broader patient population.

The expanding focus on personalized medicine is also pushing the market forward, as neuroprosthetic devices are increasingly being tailored to meet the specific needs of individual patients. Additionally, the growing investments in neurological research and development, along with favorable regulatory environments for medical devices, are creating opportunities for innovation and market expansion. The rise in public and private funding for neuroprosthetic research, particularly in brain-computer interfaces, is further accelerating the growth of this market.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • NDI Medical
  • NeuroPace, Inc.
  • Nevro Corp.
  • Retina Implant AG
  • Second Sight Medical Products, Inc.
  • Sonova Holding AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Neuroprosthetics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Incidence of Neurological Disorders and Disabilities Drives Demand for Neuroprosthetic Devices
    • Advancements in Brain-Computer Interface (BCI) Technology Propel Growth in Neuroprosthetics for Motor Function Rehabilitation
    • Rising Adoption of Cochlear Implants and Auditory Neuroprosthetics Expands Market in Hearing Restoration Applications
    • Increasing Use of Neuroprosthetics for Deep Brain Stimulation (DBS) Strengthens Business Case for Parkinsons and Epilepsy Treatment
    • Growing Integration of AI and Machine Learning in Neuroprosthetics Fuels Innovation in Personalized Rehabilitation Therapies
    • Surge in Demand for Retinal Implants and Visual Neuroprosthetics Expands Opportunities in Vision Restoration Technologies
    • Technological Advancements in Wireless Neuroprosthetics Drive Growth in Wearable and Portable Devices for Neurological Patients
    • Increasing Use of Neuroprosthetics in Spinal Cord Injury Rehabilitation Spurs Demand for Advanced Neural Interface Devices
    • Emerging Focus on Peripheral Nerve Stimulation in Neuroprosthetics Expands Applications in Pain Management and Neuroplasticity
    • Rising Adoption of Neuroprosthetics in the Treatment of Epilepsy and Tremors Expands Market for Brain Stimulation Devices
    • Growing Interest in Neuroprosthetic Solutions for Stroke Recovery Drives Innovation in Brain-Machine Interfaces for Motor Function Restoration
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neuroprosthetics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neuroprosthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Neuroprosthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Motor Neuron Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Motor Neuron Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Cognitive Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Cognitive Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Physiological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Physiological Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Spinal Cord Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Spinal Cord Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Deep Brain Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Sacral Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Sacral Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Transcranial Magnetic Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Transcranial Magnetic Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 23: USA 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • CANADA
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Canada 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • JAPAN
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Japan 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Japan 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • CHINA
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 32: China Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: China 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 34: China Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 35: China 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • EUROPE
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 37: Europe 7-Year Perspective for Neuroprosthetics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Europe 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Europe 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • FRANCE
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 42: France Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 43: France 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 44: France Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: France 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • GERMANY
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Germany 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 48: Germany Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Germany 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • ITALY
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Italy 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 52: Italy Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Italy 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • UNITED KINGDOM
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 54: UK Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 55: UK 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 56: UK Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: UK 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 60: Rest of Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Rest of Europe 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Asia-Pacific 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Rest of World 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 68: Rest of World Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of World 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030

IV. COMPETITION